This study from 2011 says point blank that tocotrienols suppress, regress, and slow the progression of arteriosclerosis, and lower serum lipids while raising HDL-C.
https://www.ncbi.nlm.nih.gov/pubmed/21774782
In studying I have found that alpha tocopherol actually inhibits the uptake and utilization of tocotrienols. They should be taken separately and perhaps alpha tocopherol should be de-emphasized in favor of tocotrienols.
This could be a valuable addition to the Pauling therapy.
Tocotrienols were relatively unstudied in Pauling's lifetime but are coming to the fore today. They may account for some of the disparity between positive outcomes in studies of dietary intake of Vitamin E versus negative outcomes in studies involving primarily alpha tocopherol supplementation.